Possible new target to attack flu virus identified

Date:

April 10, 2014

Source:

University of Texas at Austin

Summary:

A protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms, researchers have found. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus. When an influenza virus infects a human cell, it uses some of the host's cellular machinery to make copies of itself, or replicate. In this study, the researchers discovered that a protein produced by human body cells, DDX21, blocks this replication process.

Share:

Total shares:

FULL STORY

This region of the NS1 viral protein binds the host protein DDX21, making it a potential target for new antivirals against the influenza virusBetter antiviral drugs could help the millions of people annually infected by flu, which kills up to 500,000 people each year.

Credit: Image courtesy of University of Texas at Austin

This region of the NS1 viral protein binds the host protein DDX21, making it a potential target for new antivirals against the influenza virusBetter antiviral drugs could help the millions of people annually infected by flu, which kills up to 500,000 people each year.

Credit: Image courtesy of University of Texas at Austin

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

When an influenza virus infects a human cell, it uses some of the host's cellular machinery to make copies of itself, or replicate. In this study, the researchers discovered that a protein produced by human body cells, DDX21, blocks this replication process. They also discovered that a protein created by the virus, NS1, in turn blocks DDX21 and promotes viral replication.

"If you could figure out how to stop NS1 from binding to DDX21, you could stop the virus cold," said Robert Krug, a professor in the College of Natural Sciences at The University of Texas at Austin and corresponding author on the study, which appears today in the journal Cell Host and Microbe.

Krug said that in addition to countering the body's defense mechanisms, the viral NS1 protein actually performs other important roles for the virus, such as inhibiting the host's synthesis of interferon, a key antiviral protein.

"It means that if you could block that NS1 function, you'd be blocking not only its interaction with DDX21 but many other important functions, so it's a great target," said Krug.

The need for new antiviral drugs against the influenza virus is great. Because flu vaccines are not 100 percent effective, antiviral drugs play an important role in fast-spreading epidemics. Yet influenza A viruses are developing resistance to antiviral drugs currently in use.

Krug and his team discovered that the viral NS1 protein is often associated, or bound together, with the host DDX21 protein in infected human body cells. To understand what role DDX21 might play in virus replication, the researchers used a technique called siRNA gene silencing to knock down the production of DDX21 in infected cells. When they did, virus replication increased 30 fold.

"That told us that DDX21 is a host restriction factor, that it inhibits replication," said Krug. "That was the key to understanding what was happening. It was an exciting moment."

Next, the researchers discovered that DDX21 blocks replication by binding to a protein that the virus needs to replicate, called PB1. Finally, they discovered that NS1 binds to DDX21 and makes PB1 available again for replication. This result confirmed that NS1 was indeed the countermeasure used by the virus to get around the body's natural defense mechanism.

July 31, 2015  School is just around the corner, which means backpacks and packed lunches await your children. One expert offers tips for parents to promote healthy dental habits while away from ... read more

July 29, 2015  By blocking the expression of a certain gene in patients, researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their ... read more

July 29, 2015  Viewing aquarium displays led to noticeable reductions in blood pressure and heart rate, a research team found in the first study of its kind. They also noted that higher numbers of fish helped to ... read more

Feb. 27, 2014  New analysis of the influenza A virus shows potential for developing new anti-viral drugs which are more likely to be universally effective against the flu virus originating from avian, swine or ... read more

Mar. 7, 2013  Flu viruses are a major cause of death and sickness around the world, and antiviral drugs currently do not protect the most seriously ill patients. A new study reveals that a compound derived from ... read more

Aug. 23, 2012  Scientists have discovered one of the ways the influenza virus disarms our natural defense system. The virus decreases the production of key immune regulating proteins in human cells that help fight ... read more

Jan. 27, 2012  Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways ... read more